APA (7th ed.) Citation

Li, H., Ren, C., Cui, D., Wu, T., & Nie, Z. Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Huanhuan, Chao Ren, Donghai Cui, Tao Wu, and Zhiyong Nie. Case Report: Patients with Positive HER-2 Amplification Locally Advanced Gastroesophageal Junction Cancer Achieved Pathologic Complete Response with the Addition of Pembrolizumab to Chemotherapy Plus Trastuzumab as Neoadjuvant Therapy. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Huanhuan, et al. Case Report: Patients with Positive HER-2 Amplification Locally Advanced Gastroesophageal Junction Cancer Achieved Pathologic Complete Response with the Addition of Pembrolizumab to Chemotherapy Plus Trastuzumab as Neoadjuvant Therapy. Frontiers Media S.A.